✦ LIBER ✦

Efficacy and safety of a high purity, double virus inactivated factor VIII/von Willebrand factor concentrate (Biostate®) in patients with von Willebrand disorder requiring invasive or surgical procedures

✍ Scribed by J. SHORTT; S. DUNKLEY; K. RICKARD; R. BAKER; A. STREET

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical efficacy and safety of the fact

✍ S. DUNKLEY; R. I. BAKER; M. PIDCOCK; J. PRICE; M. SELDON; M. SMITH; A. STREET; D 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB

Experience with Optivate®, a new high pu

✍ C. R. M. HAY; A. HELLMANN; A. DMOSZYNSKA; T. BAGLIN; D. O’SHAUNESSEY; M. MAKRIS; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 187 KB

Pharmacokinetics of Optivate®, a high-pu

✍ A. DMOSZYNSKA; A. HELLMANN; T. BAGLIN; D. O’SHAUGNESSY; J. TRELINSKI; K. KULICZK 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 156 KB

Clinical assessment of Optivate®, a high

✍ A. DMOSZYNSKA; K. KULICZKOWSKI; A. HELLMANN; J. TRELINSKI; J. KLOCZKO; T. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 110 KB

Immune tolerance induction with a high p

✍ A. GRINGERI; R. MUSSO; M. G. MAZZUCCONI; G. PISEDDU; M. SCHIAVONI; P. PIGNOLONI; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 464 KB